NCT03312166

Brief Summary

SCARWARS study deals with the first on-human evaluation of a compressive device dedicated to the prevention of keloïd scars recurrence after surgery. The tested device is made with clinical grade silicon. SCARWARS is a monocentric study. 27 patients will be include and follow during one year. The primary outcome of this study is the number of keloid recurrence after treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2017

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 12, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 17, 2017

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2023

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

6.2 years

First QC Date

October 12, 2017

Last Update Submit

September 5, 2024

Conditions

Keywords

ear lobecompressionmedical devicerecurrence

Outcome Measures

Primary Outcomes (1)

  • Recurrence of keloid scar

    Recurrence will be assessed during each visit by surgeon

    12 month

Study Arms (1)

Compression device

EXPERIMENTAL
Device: Compression device

Interventions

interventions on patient are : * surgical excision of ear lobe keloid * application of compression device on sutured skin

Compression device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient over 18 yo;
  • Patient with aer lobe keloid;
  • Patient with an indication of reconstructive surgery;
  • Signature of informed consent from the patient;
  • Indication that the subject has understood the purpose and procedures required by the study and agrees to participate in the study and comply with the requirements and limitations inherent in this study;
  • Patient with French social insurance.

You may not qualify if:

  • Patient with cutaneous dermatosis or other skin pathology able to interfere with evaluated parameter (recurrence and healing quality);
  • Patient with know nickel allergy;
  • Patient with know silicon allergy;
  • Pregnant women;
  • Legal incapacity or limited legal capacity;
  • Patient unlikely to cooperate in the study and / or low cooperation anticipated by the investigator;
  • Patient without health insurance;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Besançon

Besançon, 25000, France

Location

MeSH Terms

Conditions

KeloidRecurrence

Interventions

Intermittent Pneumatic Compression Devices

Condition Hierarchy (Ancestors)

Collagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesCicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • Brice Chatelain, MD

    Centre Hospitalier Universitaire de Besançon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2017

First Posted

October 17, 2017

Study Start

October 3, 2017

Primary Completion

December 14, 2023

Study Completion

December 14, 2023

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations